Results 91 to 100 of about 71,291 (119)

Genetic incorporation of histidine derivatives using an engineered pyrrolysyl-tRNA synthetase. [PDF]

ACS Chem Biol, 2014
Xiao H, Peters FB, Yang PY, Reed S, Chittuluru JR, Schultz PG.   +5 more
europepmc   +1 more source

A rationally designed pyrrolysyl-tRNA synthetase mutant with a broad substrate spectrum. [PDF]

J Am Chem Soc, 2012
Wang YS, Fang X, Wallace AL, Wu B, Liu WR.   +4 more
europepmc   +1 more source

Efficient multisite unnatural amino acid incorporation in mammalian cells via optimized pyrrolysyl tRNA synthetase/tRNA expression and engineered eRF1. [PDF]

J Am Chem Soc, 2014
Schmied WH, Elsässer SJ, Uttamapinant C, Chin JW.   +3 more
europepmc   +1 more source

Pyrrolysine refusing to stop. [PDF]

Nat Chem
Jin G, Liu WR.
europepmc   +1 more source

Repurposing Engineered Aminoacyl-tRNA Synthetases for Proximity-Dependent Protein Labeling through the Release of Aminoacyl-AMP Intermediate. [PDF]

ACS Chem Biol
Yared TJ, Ficaretta ED, Voss LA, Loynd C, Singha Roy SJ, Chatterjee A.   +5 more
europepmc   +1 more source

A Genetically Encoded Electrophilic Lysine Derivative Enables Sortase-Mediated Assembly of SUMO Activity-Based Probes. [PDF]

J Am Chem Soc
Wanka V, Kvasha D, Cigler M, Heymes-Krauskopf K, Ruckgaber P, Heider A, Fottner M, Groll M, Lang K.   +8 more
europepmc   +1 more source

Co-Translational Incorporation of (<i>R</i>)- and (<i>S</i>)-β²-Hydroxyacids <i>In Vivo</i>: Directed Evolution of Efficient Aminoacyl-tRNA Synthetases. [PDF]

J Am Chem Soc
Soni C, Pressimone M, Nair M, Szalay K, Hall M, Hamlish N, Solivan AC, Schepartz A, Chatterjee A.   +8 more
europepmc   +1 more source

Engineering Protease-Resistant Peptides via Non-Canonical Amino Acids: Design Strategies and Biosynthetic Advances. [PDF]

Bioengineering (Basel)
Deng C, Fan Z, Xu Y, Cao M, Liao J, Meng M.   +5 more
europepmc   +1 more source

Expanding the Genetic Code with Lysine Aminoacylation. [PDF]

J Am Chem Soc
Li X, Gan Q, Fan C.
europepmc   +1 more source

Reprogramming AAV tropism with tumor-associated targeting ligands. [PDF]

Mol Ther Oncol
Trisno SL, Kay MA.
europepmc   +1 more source